Search

Search Constraints

You searched for: Author/Creator ,

Search Results

9444. BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report. (19th May 2021)

9445. BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5–18 Years—United States, July 2021 – April 2022. (20th August 2022)

9446. BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?. Issue 5 (19th April 2022)